Ann Rheum Dis

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
[Advanced]

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this link to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Add article to my folders
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kono, H.
Right arrow Articles by Suzuki, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kono, H.
Right arrow Articles by Suzuki, M.
Ann Rheum Dis 2000;59:372-376 ( May )

Extended report

Pneumomediastinum in dermatomyositis: association with cutaneous vasculopathy Hajime Kono, Shigeko Inokuma, Hisanori Nakayama, Mie Suzuki

Department of Allergy and Immunological Diseases, Tokyo Metropolitan Komagome Hospital, 3-18-22 Honkomagome, Bunkyo-ku, Tokyo 113-8677, Japan

Correspondence to: Dr Inokuma Email: inokuma-k{at}komagomehospital.bunkyo.tokyo.jp

Accepted for publication 2 November 1999

OBJECTIVES---To study the pathogenesis of pneumomediastinum in polymyositis/dermatomyositis (PM/DM).
PATIENTS AND METHODS---The clinical records of 48 patients with PM/DM were reviewed, focusing mainly on the presence of pneumomediastinum and cutaneous vasculopathy, and the chest radiographic changes. A patient with pneumomediastinum with a characteristic change in his bronchus is described in detail. Case reports of pneumomediastinum in PM/DM in English publications are reviewed.
RESULTS---Among the 48 patients with PM/DM, pneumomediastinum was observed as a complication in four patients with DM and none of the patients with PM. Three of the four patients with pneumomediastinum, but only six of the 44 patients without this complication, had associated cutaneous vasculopathy. There was a significant association of pneumomediastinum with cutaneous vasculopathy (p = 0.02) and younger age (p = 0.04), but not with the prevalence of lung disease. A 30 year old man (patient 1) with DM, who had interstitial pneumonitis and skin ulceration due to vasculopathy, developed pneumomediastinum. Fibreoptic bronchoscopy showed white plaques on the bronchial mucosa, which were confirmed by microscopic examination as representing subepithelial necrosis. A literature review showed 13 cases of DM but no patient with PM with pneumomediastinum.
CONCLUSIONS---In patient 1, bronchial necrosis due to vasculopathy was strongly suspected as being responsible for the pneumomediastinum. The results suggest that pneumomediastinum was associated not with interstitial pneumonitis but with the complication of vasculopathy appearing as skin lesions in DM.


© 2000 by Annals of the Rheumatic Diseases



This article has been cited by other articles:


Home page
LupusHome page
T. Sugimoto, T. Hajiro, T. Fujimoto, N. Kojyo, M. Horie, and A. Kashiwagi
Letter to the Editor: Thrombotic microangiopathy in an adult patient with clinically amyopathic dermatomyositis complicated with interstitial lung disease
Lupus, December 1, 2007; 16(12): 1004 - 1005.
[PDF]


Home page
Ann Rheum DisHome page
C Iking-Konert, B Ostendorf, G Jung, A Becker, and M Schneider
"Bubbles in the brain": an unusual complication of dermatomyositis
Ann Rheum Dis, April 1, 2006; 65(4): 550 - 551.
[Full Text] [PDF]


Home page
Rheumatology (Oxford)Home page
C. Korkmaz, R. Ozkan, M. Akay, and T. Hakan
Pneumomediastinum and subcutaneous emphysema associated with dermatomyositis
Rheumatology, April 1, 2001; 40(4): 476 - 478.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
Terms and conditions relating to subscriptions purchased online  ¦  Website terms and conditions  ¦  Privacy policy
Copyright © 2000 BMJ Publishing Group Ltd & European League Against Rheumatism